{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T05:01:39Z","timestamp":1788238899513,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T00:00:00Z","timestamp":1647820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T00:00:00Z","timestamp":1647820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00520-022-06970-2","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T19:03:37Z","timestamp":1647889417000},"page":"5519-5526","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Anemia requiring transfusion in breast cancer patients on dose-dense chemotherapy: Prevalence, risk factors, cost and effect on disease outcome"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4954-6031","authenticated-orcid":false,"given":"Parth","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7119-9710","authenticated-orcid":false,"given":"Josh Thomas","family":"Georgy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand George","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajoy Oommen","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjana","family":"Joel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raju Titus","family":"Chacko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanna Samuel","family":"Premkumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,21]]},"reference":[{"issue":"21","key":"6970_CR1","doi-asserted-by":"publisher","first-page":"4747","DOI":"10.1182\/blood.V118.21.4747.4747","volume":"118","author":"GK John","year":"2011","unstructured":"John GK, Sanamandra S, Shet AS (2011 Nov) Cancer related anemia in the developing world: risk factors and treatment patterns. Blood 118(21):4747","journal-title":"Blood"},{"key":"6970_CR2","doi-asserted-by":"publisher","unstructured":"Kifle E, Hussein M, Alemu J, Tigeneh W. Prevalence of Anemia and Associated Factors among Newly Diagnosed Patients with Solid Malignancy at Tikur Anbessa Specialized Hospital, Radiotherapy Center, Addis Ababa, Ethiopia. Adv Hematol. 2019;2019:8279789. Published 2019 Oct 20.\u00a0https:\/\/doi.org\/10.1155\/2019\/8279789","DOI":"10.1155\/2019\/8279789"},{"issue":"1","key":"6970_CR3","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3324\/haematol.2014.112813","volume":"100","author":"A Macci\u00f2","year":"2015","unstructured":"Macci\u00f2 A, Madeddu C, Gramignano G, Mulas C, Tanca L, Cherchi MC et al (2015) The role of inflammation, iron, and nutritional status in cancer-related anemia: results of a large, prospective, observational study. Haematologica 100(1):124\u2013132","journal-title":"Haematologica"},{"issue":"15","key":"6970_CR4","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1016\/j.ejca.2004.06.019","volume":"40","author":"H Ludwig","year":"2004","unstructured":"Ludwig H, Van Belle S, Barrett-Lee P, Birgeg\u00e5rd G, Bokemeyer C, Gasc\u00f3n P et al (2004) The European cancer anaemia survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer 40(15):2293\u20132306","journal-title":"Eur J Cancer"},{"key":"6970_CR5","doi-asserted-by":"publisher","unstructured":"Kanuri G, Sawhney R, Varghese J, Britto M, Shet A. Iron Deficiency Anemia Coexists with Cancer Related Anemia and Adversely Impacts Quality of Life. PLoS One. 2016;11(9):e0163817. Published 2016 Sep 28.\u00a0https:\/\/doi.org\/10.1371\/journal.pone.0163817","DOI":"10.1371\/journal.pone.0163817"},{"issue":"4","key":"6970_CR6","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/00000421-200208000-00011","volume":"25","author":"F Tas","year":"2002","unstructured":"Tas F, Eralp Y, Basaran M, Sakar B, Alici S, Argon A et al (2002) Anemia in oncology practice: relation to diseases and their therapies. Am J Clin Oncol 25(4):371\u2013379","journal-title":"Am J Clin Oncol"},{"issue":"7 SUPPL. 1","key":"6970_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.amjmed.2003.12.008","volume":"116","author":"K Knight","year":"2004","unstructured":"Knight K, Wade S, Balducci L (2004) Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med 116(7 SUPPL. 1):11\u201326","journal-title":"Am J Med"},{"key":"6970_CR8","doi-asserted-by":"publisher","unstructured":"Glaspy J. Anemia and fatigue in cancer patients. Cancer. 2001;92(6 Suppl):1719-1724.\u00a0https:\/\/doi.org\/10.1002\/1097-0142(20010915)92:6+<1719::aid-cncr1503>3.0.co;2-5","DOI":"10.1002\/1097-0142(20010915)92:6+<1719::aid-cncr1503>3.0.co;2-5"},{"issue":"SUPPL. 1","key":"6970_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1054\/bjoc.2001.1750","volume":"84","author":"GD Demetri","year":"2001","unstructured":"Demetri GD (2001) Anaemia and its functional consequences in cancer patients: current challenges in management and prospects for improving therapy. Br J Cancer 84(SUPPL. 1):31\u201337","journal-title":"Br J Cancer"},{"issue":"10","key":"6970_CR10","first-page":"640","volume":"18","author":"S Anand","year":"2020","unstructured":"Anand S, Burkenroad A, Glaspy J (2020) Workup of anemia in cancer. Clin Adv Hematol Oncol HO 18(10):640\u2013646","journal-title":"Clin Adv Hematol Oncol HO"},{"issue":"4","key":"6970_CR11","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.breast.2011.10.009","volume":"21","author":"N Chaumard","year":"2012","unstructured":"Chaumard N, Limat S, Villanueva C, Nerich V, Fagnoni P, Bazan F et al (2012) Incidence and risk factors of anemia in patients with early breast cancer treated by adjuvant chemotherapy. Breast 21(4):464\u2013467","journal-title":"Breast"},{"issue":"1","key":"6970_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00520-019-04780-7","volume":"28","author":"A Razzaghdoust","year":"2020","unstructured":"Razzaghdoust A, Mofid B, Peyghambarlou P (2020) Predictors of chemotherapy-induced severe anemia in cancer patients receiving chemotherapy. Support Care Cancer 28(1):155\u2013161","journal-title":"Support Care Cancer"},{"issue":"1","key":"6970_CR13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1159\/000091675","volume":"70","author":"PJ Barrett-Lee","year":"2006","unstructured":"Barrett-Lee PJ, Ludwig H, Birgeg\u00e5rd G, Bokemeyer C, Gasc\u00f3n P, Kosmidis PA et al (2006) Independent risk factors for anemia in cancer patients receiving chemotherapy: results from the European cancer anaemia survey. Oncology 70(1):34\u201348","journal-title":"Oncology"},{"issue":"3","key":"6970_CR14","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00520-006-0154-2","volume":"15","author":"M Vincent","year":"2007","unstructured":"Vincent M, Dranitsaris G, Verma S, Lau C, Gascon P, Van Belle S et al (2007) The development and validation of a prediction tool for chemotherapy-induced anemia in patients with advanced nonsmall cell lung cancer receiving palliative chemotherapy. Support Care Cancer 15(3):265\u2013272","journal-title":"Support Care Cancer"},{"issue":"10","key":"6970_CR15","doi-asserted-by":"publisher","first-page":"4263","DOI":"10.1007\/s00520-016-3258-3","volume":"24","author":"L Family","year":"2016","unstructured":"Family L, Xu L, Xu H, Cannavale K, Sattayapiwat O, Page JH et al (2016) The effect of chemotherapy-induced anemia on dose reduction and dose delay. Support Care Cancer 24(10):4263\u20134271","journal-title":"Support Care Cancer"},{"issue":"1","key":"6970_CR16","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1200\/JCO.2014.57.0572","volume":"33","author":"WM Sikov","year":"2015","unstructured":"Sikov WM, Berry DA, Perou CM, Singh B, Cirrincione CT, Tolaney SM et al (2015) Impact of the addition of carboplatin and\/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (alliance). J Clin Oncol 33(1):13\u201321","journal-title":"J Clin Oncol"},{"issue":"4","key":"6970_CR17","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S1470-2045(18)30111-6","volume":"19","author":"S Loibl","year":"2018","unstructured":"Loibl S, O\u2019Shaughnessy J, Untch M, Sikov WM, Rugo HS, McKee MD et al (2018) Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial. Lancet Oncol 19(4):497\u2013509","journal-title":"Lancet Oncol"},{"issue":"31","key":"6970_CR18","doi-asserted-by":"publisher","first-page":"S343","DOI":"10.1016\/j.annonc.2020.08.070","volume":"1","author":"JT Georgy","year":"2020","unstructured":"Georgy JT, Singh A, Oommen A, Joel A, Manipadam MT, Abraham DT et al (2020) 261P A novel dose-dense alternating regimen of Docetaxel-Cyclophosphamide with Epirubicin-Cisplatin (ddDCEP) as neoadjuvant chemotherapy (NACT) for high-risk triple-negative breast cancer. Ann Oncol 1(31):S343","journal-title":"Ann Oncol"},{"key":"6970_CR19","unstructured":"WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva, World Health Organization, 2011(WHO\/NMH\/NHD\/MNM\/11.1) (http:\/\/www.who.int\/vmnis\/indicators\/haemoglobin.pdf); accessed [15-12-2021]"},{"issue":"8","key":"6970_CR20","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1200\/JCO.2003.09.081","volume":"21","author":"ML Citron","year":"2003","unstructured":"Citron ML, Berry DA, Cirrincione C, Hudis C, Winer EP, Gradishar WJ et al (2003) Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741\/Cancer and Leukemi. J Clin Oncol Off J Am Soc Clin Oncol 21(8):1431\u20131439","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"14","key":"6970_CR21","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1093\/jnci\/djt145","volume":"105","author":"V Moebus","year":"2013","unstructured":"Moebus V, Jackisch C, Schneeweiss A, Huober J, Lueck HJ, Du Bois A et al (2013) Adding epoetin alfa to intense dose-dense adjuvant chemotherapy for breast cancer: Randomized clinical trial. J Natl Cancer Inst 105(14):1018\u20131026","journal-title":"J Natl Cancer Inst"},{"issue":"8","key":"6970_CR22","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(03)01163-X","volume":"4","author":"B Leyland-Jones","year":"2003","unstructured":"Leyland-Jones B (2003) Breast cancer trial with erythropoietin terminated unexpectedly. Lancet Oncol 4(8):459\u2013460","journal-title":"Lancet Oncol"},{"issue":"7","key":"6970_CR23","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/annonc\/mdy127","volume":"29","author":"F Poggio","year":"2018","unstructured":"Poggio F, Bruzzone M, Ceppi M, Pond\u00e9 NF, La Valle G, Del Mastro L et al (2018) Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis. Ann Oncol Off J Eur Soc Med Oncol 29(7):1497\u20131508","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"1","key":"6970_CR24","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1186\/1471-2407-14-844","volume":"14","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Chen Y, Chen D, Jiang Y, Huang W, Ouyang H et al (2014) Impact of preoperative anemia on relapse and survival in breast cancer patients. BMC Cancer 14(1):844","journal-title":"BMC Cancer"},{"issue":"1","key":"6970_CR25","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.3747\/co.23.2840","volume":"23","author":"X Pan","year":"2016","unstructured":"Pan X, Lu Y, Cheng X, Wang J (2016) Hepcidin and ferroportin expression in breast cancer tissue and serum and their relationship with anemia. Curr Oncol 23(1):e24\u2013e26","journal-title":"Curr Oncol"},{"issue":"3","key":"6970_CR26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1040-8428(99)00034-7","volume":"31","author":"C Elston","year":"1999","unstructured":"Elston C (1999) Pathological prognostic factors in breast cancer. Crit Rev Oncol Hematol 31(3):209\u2013223","journal-title":"Crit Rev Oncol Hematol"},{"issue":"10","key":"6970_CR27","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.3389\/fphys.2019.01294","volume":"9","author":"A Pagani","year":"2019","unstructured":"Pagani A, Nai A, Silvestri L, Camaschella C (2019) Hepcidin and anemia: a tight relationship. Front Physiol 9(10):1294","journal-title":"Front Physiol"},{"issue":"5","key":"6970_CR28","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s00520-012-1671-9","volume":"21","author":"S Shreay","year":"2013","unstructured":"Shreay S, Desrosiers MP, Corey-Lisle P, Payne K (2013) A retrospective study to evaluate the time burden associated with outpatient red blood transfusions indicated for anemia due to concomitantly administered chemotherapy in cancer patients. Support Care Cancer 21(5):1335\u20131340","journal-title":"Support Care Cancer"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-06970-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-022-06970-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-06970-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T07:31:42Z","timestamp":1744183902000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-022-06970-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,21]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["6970"],"URL":"https:\/\/doi.org\/10.1007\/s00520-022-06970-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-990324\/v1","asserted-by":"object"}]},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,21]]},"assertion":[{"value":"18 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board and Ethics committee, Christian Medical College Vellore, Tamil Nadu, India (IRB number: 13960 [Retro] dated 28.04.21).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The patients consented for treatment and collection of data prior to initiation of treatment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"As this was a retrospective study consent for publication was waived by the Institutional Ethics Committee.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}